Navigation Links
Bernstein Liebhard LLP Notes More Than 2,800 Ethicon Mesh Lawsuits Now Pending in New Jersey Litigation

New York, NY (PRWEB) June 03, 2013

The number of Ethicon mesh lawsuits involving the Johnson & Johnson subsidiary’s brand of Gynecare pelvic mesh implants continues to grow in a consolidated litigation established in New Jersey’s Atlantic County Superior Court, Bernstein Liebhard LLP reports. According to a Case List posted on the Court’s website on May 28th, 2,831 surgical mesh lawsuits have now been filed in the litigation by women alleging mesh erosion, infection and other injuries stemming from Ethicon mesh devices. Bernstein Liebhard LLP has filed several lawsuits in this proceeding on behalf of women who claim the implants marketed by Ethicon were defectively designed, and that the company failed to warn consumers of their serious risks for injury. Firm partner, Jeffrey S. Grand, is serving as Co-Liaison Counsel for this litigation. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10).*

“We continue to hear from women on a regular basis who have allegedly suffered injuries stemming from Ethicon mesh products. That said, we are not surprised that the number of claims pending in the consolidated litigation underway in New Jersey has now surpassed 2,800,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices.

Surgical Mesh Lawsuits
Vaginal mesh products have been the subject of mounting concern since October 2008, when the U.S. Food and Drug Administration (FDA) alerted the public that it had received more than 1,000 adverse event reports associated with the implants over a period of three years. A little less than three years later, the FDA re-classified the frequency of complications to occur in women implanted with vaginal mesh as “not rare” after receiving an estimated 2,800 complaint reports since the 2008 safety communication. According to the agency, some of the most common side effects associated with transvaginal mesh devices, which are used to treat pelvic organ prolapse and stress urinary incontinence in women, include mesh erosion through the vaginal epithelium, pain, urinary problems and infection.**

In March, the plaintiff in the first Ethicon mesh lawsuit to head to trial in the U.S. won more than $11 million, including $7.76 million in punitive damages, after a jury in New Jersey Superior Court found that the manufacturer failed to warn of the side effects that may stem from its products. Jeffrey S. Grand, a partner at Bernstein Liebhard LLP, served on the trial team for this surgical mesh lawsuit. (Gross v. Gynecare Inc., Atl-L-6966-10, Superior Court of Atlantic County, New Jersey)

Mr. Grand is also serving as Co-Liaison Counsel for a consolidated litigation underway in Atlantic County Superior Court for lawsuits involving pelvic mesh manufactured by C.R. Bard Inc. (In re: Pelvic Mesh Litigation/Bard, No. L-6339-10), and is a member of the Plaintiffs’ Steering Committees in four federal transvaginal mesh multi-district litigations underway in U.S. District Court, Southern District of West Virginia. These proceedings include: In re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2326); In re: C.R. Bard, Inc., In Re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2325”); In re: C.R. Bard, Inc., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2187”); and In re: Ethicon, Inc., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2327”).

Women allegedly injured as a result of being implanted with transvaginal mesh may be eligible to seek compensation for medical expenses, pain and suffering and other damages. Learn more about how to file a surgical mesh lawsuit by visiting Bernstein Liebhard's website, or by contacting one of the Firm’s attorneys directly at 800-511-5092.


About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(800) 511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
# # #

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DePuy ASR Hip Recall Lawsuits: Bernstein Liebhard LLP Notes Plaintiffs’ Opposition to Defense Motion on Punitive Damages in Federal DePuy ASR Lawsuits
2. Vaginal Mesh Lawyers at Bernstein Liebhard LLP Note Recent Developments in Federal Transvaginal Mesh Lawsuits
3. Actos Lawsuits: Bernstein Liebhard LLP Notes More Than 1,500 Cases Now Filed in Federal Litigation
4. Pradaxa Lawsuits Move Ahead As Bernstein Liebhard LLP Notes Upcoming Status Conference in Federal Pradaxa Litigation
5. Stryker Hip Lawsuits Filed in Wake of Rejuvenate and ABG II Hip Stem Recall Continue to Mount in New Jersey Superior Court, Bernstein Liebhard LLP Reports
6. Da Vinci Lawsuit Update: Bernstein Liebhard LLP Notes Commencement of Shareholder Class Action Da Vinci Related Lawsuit Against Intuitive Surgical
7. DePuy Hip Replacement Recall News: Bernstein Liebhard LLP Notes New Case Management Order in New Jersey DePuy Hip Recall Litigation
8. Vaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes New Pretrial Order in Federal Transvaginal Mesh Litigation
9. Actos Lawsuits Move Forward, as Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Actos Bladder Cancer Litigation
10. Mirena Lawsuit News: Bernstein Liebhard LLP Notes Establishment of Mirena Side Effects Litigation in New Jersey Superior Court, Issuance of First Case Management Order
11. DePuy ASR Hip Lawsuit Judge Upholds $8.3 Million Verdict in Nation’s First Trial Stemming from 2010 DePuy ASR Recall, Bernstein Liebhard LLP Reports
Post Your Comments:
(Date:11/29/2015)... ... November 29, 2015 , ... ... unique analog distortion effect tool designed specially for Final Cut Pro X. ... limiltess looks with the easy-to-use modification controls. Destoying and creating chaotic distortion is ...
(Date:11/28/2015)... ... , ... Trying to relax on a couch can actually be uncomfortable, so ... design due to personal experience with a bad back," he said. , This easy-to-use, ... well as increases support. It also makes it easier to eat, do other activities ...
(Date:11/27/2015)... ... November 27, 2015 , ... According to an ... the University of Toronto and the University of British Columbia suggested that laws requiring ... injuries. The article explains that part of the reason for the controversial conclusion is ...
(Date:11/27/2015)... , ... November 27, 2015 , ... ... the toilets were," said an inventor from Hillside, N.J. "Many people catch diseases ... cover so that individuals will always be protected from germs." , He developed ...
(Date:11/27/2015)... , ... November 27, 2015 , ... ... of progress through sharing, the 2016 Building Better Radiology Marketing Programs ... will begin on Sunday, March 6, 2016, at Caesars Palace in Las Vegas ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... November 26, 2015 ... addition of the  "2016 Future Horizons ... Therapeutic Drug Monitoring (TDM) Market: Supplier ... Emerging Opportunities"  report to their offering.  ... announced the addition of the  "2016 ...
(Date:11/26/2015)... , November 26, 2015 ... of the "Radioimmunoassay Market by Type ... Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application ... Forecast to 2020" report to their ... announced the addition of the "Radioimmunoassay ...
(Date:11/25/2015)...  Amgen (NASDAQ: AMGN ) today announced the ... the United States (U.S.) Food and ... to Humira ® (adalimumab). Amgen believes this submission ... FDA and represents Amgen,s first BLA submission using the ... M.D., executive vice president of Research and Development at ...
Breaking Medicine Technology: